TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has announced the conversion of 5 bonds from its convertible bond loan with Global Growth Holding Limited, resulting in the issuance of 357,142 new shares at a conversion price of Euro 0.14 per share. This conversion increases the company’s share capital by Euro 50,000, bringing the total number of shares to 20,048,739. The move is part of a larger capital increase plan to service the bond loan, with implications for the company’s financial structure and market presence.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on the Euronext Milan market, is a global leader in the design, production, and marketing of high-performance integrated milling systems. The company primarily serves the automotive and aerospace sectors, offering solutions that cover the entire milling process. With over 40 years of experience and approximately 135 employees, Fidia specializes in numerical controls, high-speed milling systems, and CAM software for complex shapes.
Average Trading Volume: 577,862
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.61M
See more insights into FDA stock on TipRanks’ Stock Analysis page.